Luc Furic Selected Research

Luc Furic Research Topics

Disease

18	Neoplasms (Cancer) 01/2023 - 11/2009
15	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 08/2010
4	Carcinoma (Carcinomatosis) 01/2018 - 12/2010
3	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2011
3	Carcinogenesis 11/2016 - 11/2009
2	Disease Progression 06/2019 - 01/2018
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2021
1	Breast Neoplasms (Breast Cancer) 06/2021
1	Adenocarcinoma 01/2021
1	Hypertrophy 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 11/2016
1	Virus Diseases (Viral Diseases) 04/2012
1	Prostatic Diseases 01/2012
1	Glioblastoma (Glioblastoma Multiforme) 12/2010
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2010
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2010

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 06/2021 - 08/2010
5	Eukaryotic Initiation Factor-4EIBA 04/2012 - 11/2009
4	AndrogensIBA 07/2020 - 01/2012
3	ProteomeIBA 01/2023 - 12/2019
3	Androgen Receptors (Androgen Receptor)IBA 11/2021 - 11/2018
3	Hormones (Hormone)IBA 06/2021 - 09/2014
3	Phosphotransferases (Kinase)IBA 01/2018 - 03/2011
2	RNA Polymerase I (Polymerase I, RNA)IBA 11/2021 - 11/2016
2	CX 5461IBA 11/2021 - 11/2016
2	Estrogen ReceptorsIBA 06/2021 - 01/2015
2	abirateroneIBA 01/2021 - 11/2018
2	RNA (Ribonucleic Acid)IBA 01/2021 - 11/2016
2	enzalutamideIBA 01/2021 - 11/2018
2	Estrogen Receptor alphaIBA 12/2019 - 01/2015
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 08/2019 - 06/2019
2	proto-oncogene proteins pimIBA 01/2018 - 11/2016
2	Peptide Initiation Factors (Initiation Factor)IBA 03/2011 - 11/2009
1	MTOR InhibitorsIBA 01/2023
1	Radioisotopes (Radionuclides)IBA 01/2022
1	PSMA I&TIBA 01/2022
1	CalciumIBA 01/2022
1	Radium-223IBA 01/2022
1	talazoparibIBA 11/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2021
1	Transcription Factors (Transcription Factor)IBA 06/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 06/2021
1	lysophosphatidylinositolIBA 07/2020
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 07/2020
1	Adenosine Triphosphate (ATP)IBA 07/2020
1	Docetaxel (Taxotere)FDA Link 07/2020
1	Cysteine (L-Cysteine)FDA Link 01/2020
1	Prorenin ReceptorIBA 08/2019
1	Adenosine Triphosphatases (ATPase)IBA 08/2019
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 08/2019
1	TensinsIBA 08/2019
1	Therapeutic UsesIBA 01/2019
1	TOR Serine-Threonine KinasesIBA 01/2019
1	LipidsIBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2018
1	AMP-Activated Protein KinasesIBA 01/2018
1	Ribosomal RNAIBA 11/2016
1	CX-6258IBA 11/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2015
1	Estrogens (Estrogen)FDA Link 01/2015
1	CytokinesIBA 09/2014
1	AgarIBA 03/2011
1	enzastaurinIBA 12/2010
1	Messenger RNA (mRNA)IBA 11/2009

Therapy/Procedure

8	Therapeutics 01/2022 - 03/2011
5	Castration 01/2022 - 11/2016
2	Drug Therapy (Chemotherapy) 01/2022 - 07/2020
1	Prostatectomy (Retropubic Prostatectomy) 03/2021
1	Oral Administration 11/2016